Company Filing History:
Years Active: 2008
Title: Innovations of Guangcheng Kevin Liu in Pharmaceutical Patents
Introduction
Guangcheng Kevin Liu is an influential inventor based in San Diego, California. He is recognized for his contributions to the field of pharmaceuticals, specifically through his innovative work in developing compounds beneficial for human health.
Latest Patents
Liu holds a patent for hPPARs activators, which includes compounds of formula (1) or pharmaceutically acceptable salts, solvates, acid isosteres, or hydrolyzable esters thereof. This patent discloses various methods of making and using these compounds, particularly emphasizing their applications in treating diseases or conditions associated with one or more of human PPAR alpha, gamma, or delta (hPPARs). The administration of a therapeutically effective amount of a compound of formula (1) represents a significant breakthrough in therapeutic approaches.
Career Highlights
Currently, Guangcheng Kevin Liu is employed at SmithKline Beecham Corporation. His role revolves around research and development, focusing on innovative pharmaceutical solutions that address various health conditions. His dedication to scientific advancement is evident through his successful patent and ongoing projects.
Collaborations
Liu collaborates with a talented team at SmithKline Beecham Corporation, including notable coworkers such as Rodolfo Cadilla and Brad Richard Henke. Together, they work towards the common goal of advancing pharmaceutical sciences and developing groundbreaking therapies.
Conclusion
Guangcheng Kevin Liu’s contributions to the field of pharmaceutical patents illustrate the impact of innovation in healthcare. His work on hPPARs activators highlights the potential of new compounds to change the landscape of treatment for various diseases. As he continues his work at SmithKline Beecham Corporation, the medical community eagerly anticipates further advancements stemming from his research.